Bristol-Myers Squibb & Co. BMY on Monday released topline results from a phase 2 study evaluating Reblozyl for anemia in ...
Mandy Boontanrart, PhD, a postdoc at ETH Zurich in Switzerland, has a particularly personal motivation for her research on a novel genetic therapy for sickle cell disease (SCD). She is a carrier of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results